• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺髓样癌亚群中RET原癌基因的异质性突变。

Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma.

作者信息

Eng C, Mulligan L M, Healey C S, Houghton C, Frilling A, Raue F, Thomas G A, Ponder B A

机构信息

Cancer Research Campaign Human Cancer Genetics Research Group, University of Cambridge, Addenbrooke's Hospital, United Kingdom.

出版信息

Cancer Res. 1996 May 1;56(9):2167-70.

PMID:8616867
Abstract

Mutations in the RET proto-oncogene are associated with the pathogenesis of medullary thyroid carcinoma (MTC). In an attempt to understand this process, we examined microdissected subpopulations from MTC and multiple metastases from these tumors. Approximately 80% of sporadic MTC's had at least one subpopulation with the RET codon 918 mutation, which is a mutation previously detected in sporadic MTC as a somatic mutation and in multiple endocrine neoplasia type 2B as a germline mutation. However, the distribution of this mutation was nonhomogeneous, occurring only in subpopulations in most tumors and among subsets of multiple metastases, thus implying that although the codon 918 mutation could be an early event, it is not necessarily an early or essential event in tumorigenesis. This heterogeneity suggests either that the codon 918 mutation can arise as an event in progression within a metastatic clone or within a single tumor, or that MTC can be of polyclonal origin. Of significance, one of two multiple endocrine neoplasia type 2A MTCs carried a somatic mutation at codon 918, in addition to the RET mutation present in the germline. We found no correlation between the presence of other somatic genetic events, such as loss of heterozygosity on chromosome arms 1p and 22q, and RET mutation status in the various subpopulations of MTC.

摘要

RET原癌基因的突变与甲状腺髓样癌(MTC)的发病机制相关。为了理解这一过程,我们检查了从MTC及其多处转移灶中显微切割得到的亚群。大约80%的散发性MTC至少有一个亚群存在RET密码子918突变,该突变先前在散发性MTC中作为体细胞突变被检测到,在2B型多发性内分泌腺瘤病中作为种系突变被检测到。然而,这种突变的分布并不均匀,仅在大多数肿瘤的亚群以及多处转移灶的子集中出现,因此这意味着尽管密码子918突变可能是一个早期事件,但它不一定是肿瘤发生过程中的早期或必要事件。这种异质性表明,要么密码子918突变可作为转移克隆内或单个肿瘤进展过程中的一个事件出现,要么MTC可能起源于多克隆。值得注意的是,在两个2A型多发性内分泌腺瘤病的MTC中,除了种系中存在的RET突变外,有一个还携带密码子918的体细胞突变。我们发现,在MTC的各个亚群中,其他体细胞遗传事件(如1号染色体臂和22号染色体臂杂合性缺失)的存在与RET突变状态之间没有相关性。

相似文献

1
Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma.甲状腺髓样癌亚群中RET原癌基因的异质性突变。
Cancer Res. 1996 May 1;56(9):2167-70.
2
Mutation of the RET proto-oncogene is correlated with RET immunostaining in subpopulations of cells in sporadic medullary thyroid carcinoma.RET原癌基因的突变与散发性甲状腺髓样癌中细胞亚群的RET免疫染色相关。
J Clin Endocrinol Metab. 1998 Dec;83(12):4310-3. doi: 10.1210/jcem.83.12.5345.
3
Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".通过RET原癌基因突变分析区分散发性和遗传性甲状腺髓样癌(MTC)。“奥地利多内分泌腺瘤研究小组(SMENA)”
Int J Cancer. 1996 Aug 22;69(4):312-6. doi: 10.1002/(SICI)1097-0215(19960822)69:4<312::AID-IJC13>3.0.CO;2-7.
4
RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.2型多发性内分泌腺瘤病和甲状腺髓样癌中的RET原癌基因突变
Horm Res. 1997;47(4-6):168-78. doi: 10.1159/000185461.
5
Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma.MEN 2A、MEN 2B、家族性或散发性甲状腺髓样癌患者RET原癌基因异常分析。
J Endocrinol Invest. 1998 Jun;21(6):358-64. doi: 10.1007/BF03350771.
6
Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma.散发性甲状腺髓样癌中RET原癌基因的体细胞突变。
Clin Endocrinol (Oxf). 1996 Mar;44(3):249-57. doi: 10.1046/j.1365-2265.1996.681503.x.
7
[Somatic ret proto-oncogene mutations in sporadic C-cell carcinoma of the thyroid gland].[甲状腺散发性C细胞癌中的体细胞RET原癌基因突变]
Chirurg. 1997 Aug;68(8):789-93. doi: 10.1007/s001040050271.
8
Genome-wide copy number imbalances identified in familial and sporadic medullary thyroid carcinoma.在家族性和散发性甲状腺髓样癌中鉴定出的全基因组拷贝数失衡。
J Clin Endocrinol Metab. 2003 Apr;88(4):1866-72. doi: 10.1210/jc.2002-021155.
9
Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s.通过对散发性甲状腺髓样癌(MTC)进行筛查,在RET原癌基因中鉴定出的体细胞和MEN 2A新发突变。
Hum Mol Genet. 1994 Aug;3(8):1259-62. doi: 10.1093/hmg/3.8.1259.
10
Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.散发性甲状腺髓样癌中ret原癌基因的体细胞突变并不局限于第16外显子,且与肿瘤复发相关。
J Clin Endocrinol Metab. 1996 Apr;81(4):1619-22. doi: 10.1210/jcem.81.4.8636377.

引用本文的文献

1
Hereditary Medullary Thyroid Cancer: Genotype-Phenotype Correlation.遗传性甲状腺髓样癌:基因型与表型的相关性
Recent Results Cancer Res. 2025;223:183-209. doi: 10.1007/978-3-031-80396-3_7.
2
Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the .甲状腺髓样癌的分子基础与自然史:(几乎)都与……有关 。 (你提供的原文最后不完整,所以译文也只能到这个程度)
Cancers (Basel). 2023 Oct 5;15(19):4865. doi: 10.3390/cancers15194865.
3
Lymph node metastases in pediatric medullary thyroid carcinoma.儿童髓样甲状腺癌的淋巴结转移。
Surgery. 2021 Sep;170(3):736-742. doi: 10.1016/j.surg.2021.03.001. Epub 2021 Apr 8.
4
A Narrative Review of Genetic Alterations in Primary Thyroid Epithelial Cancer.原发性甲状腺上皮癌遗传改变的叙述性综述。
Int J Mol Sci. 2021 Feb 9;22(4):1726. doi: 10.3390/ijms22041726.
5
Genomics and Epigenomics of Medullary Thyroid Carcinoma: From Sporadic Disease to Familial Manifestations.《散发性与家族性髓样甲状腺癌的基因组学和表观基因组学研究》
Endocr Pathol. 2021 Mar;32(1):35-43. doi: 10.1007/s12022-021-09664-3. Epub 2021 Jan 25.
6
RET mutated C-cells proliferate more rapidly than non-mutated neoplastic cells.RET基因变异的C细胞比未变异的肿瘤细胞增殖更快。
Endocr Connect. 2021 Feb;10(2):124-130. doi: 10.1530/EC-20-0589.
7
Updates in the advances of sporadic medullary thyroid carcinoma: from the molecules to the clinic.散发性甲状腺髓样癌进展的最新情况:从分子到临床
Gland Surg. 2020 Oct;9(5):1847-1856. doi: 10.21037/gs-2019-catp-21.
8
Current status of the prognostic molecular markers in medullary thyroid carcinoma.甲状腺髓样癌预后分子标志物的现状
Endocr Connect. 2020 Dec;9(12):R251-R263. doi: 10.1530/EC-20-0374.
9
A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer.序贯使用酵母-CEA 治疗性癌症疫苗和抗 PD-L1 抑制剂治疗转移性甲状腺髓样癌 1 例报告
Front Endocrinol (Lausanne). 2020 Aug 7;11:490. doi: 10.3389/fendo.2020.00490. eCollection 2020.
10
Modulatory Role of Single Nucleotide Polymorphisms of Distinct Genetic Pathways on Clinical Behavior of Medullary Thyroid Carcinoma.不同遗传途径中单核苷酸多态性对髓样甲状腺癌临床行为的调节作用。
Asian Pac J Cancer Prev. 2020 May 1;21(5):1289-1293. doi: 10.31557/APJCP.2020.21.5.1289.